Antiplatelet Therapy and the Risk of Bleeding Induced by Gastrointestinal Endoscopic Procedures
Authors:
- N.A. KimchiNKN.A. Kimchi
- E. BroideEBE. Broide
- E. ScapaESE. Scapa
- S. BirkenfeldSBS. Birkenfeld
- 1 January 2007
- journal article
- review article
- Published by S. Karger AG in Digestion
- Vol. 75 (1) , 36-45
Abstract
Antiplatelet drugs may increase the risk of bleeding induced by gastrointestinal endoscopic procedures. The antiplatelet effect of cyclooxygenase-1 inhibitors lasts less than 4 h. Skin and colonic bleeding times are prolonged for 3 and 5 days after aspirin and ticlopidine withdrawal respectively. Major bleeding from endoscopic biopsies is extremely rare. In the four recent largest series, the general incidence of polypectomy-induced major bleeding was 0.11–0.42%. In more than half of the cases the bleeding was delayed, usually up to 2 weeks after the endoscopy. Although three retrospective studies suggested that aspirin does not increase the risk of polypectomy-induced bleeding, the power of these studies is limited. Similarly, it is difficult to draw conclusions from the two studies that assessed the risk of aspirin use during sphincterotomy. Aspirin withdrawal may be harmful in susceptible patients, mainly if it is for more than 7 days. There is no indication to stop aspirin before esophagogastroduodenoscopy, which may reveal aspirin-induced lesions. We recommend discontinuation of aspirin 4–7 days (according to the cardiovascular risk) before other endoscopic procedures. When aspirin is indicated for primary prevention, it can be resumed 14 and 10 days after polypectomy and sphincterotomy respectively. In cases of secondary prevention, it should be resumed after 1 week.Keywords
This publication has 45 references indexed in Scilit:
- Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic proceduresJournal of Gastroenterology, 2005
- Coronary syndromes following aspirin withdrawalJACC, 2005
- Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary SyndromesCirculation, 2004
- Postpolypectomy Lower Gastrointestinal Bleeding: Potential Role of AspirinAmerican Journal of Gastroenterology, 2004
- Gastrointestinal endoscopy and the patient with a risk of bleeding disorderGastrointestinal Endoscopy, 1999
- Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE membersGastrointestinal Endoscopy, 1996
- Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDsGastrointestinal Endoscopy, 1994
- Endoscopic sphincterotomy complications and their management: an attempt at consensusGastrointestinal Endoscopy, 1991
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Effects of Acetylsalicylic Acid Ingestion on Maternal and Neonatal HemostasisNew England Journal of Medicine, 1982